HOME >> MEDICINE >> NEWS
Wide racial disparities found in coronary artery disease deaths

DURHAM, N.C. -- African-American patients with coronary artery disease die at a significantly higher rate than white patients with the same degree of disease, according to an analysis of more than 20,000 patients by cardiologists at the Duke Clinical Research Institute.

Among patients diagnosed with serious coronary disease who were followed for an average nine years, the researchers found that blacks have had a 36 percent survival rate while whites have had a 46 percent survival rate.

The researchers said the disparity can be partially by the findings that blacks tend to have higher rates of other medical conditions, which can complicate or contribute to heart problems, and that blacks do not receive coronary artery bypass surgery as often. But the researchers stressed that other unproven factors almost certainly are involved and that further research is needed to identify them and quantify their contributions.

"As prevention becomes a key point of emphasis in treating heart disease, it is vitally important to identify risk factors and to act on them," said cardiology fellow Kevin Thomas, M.D., who reported the results of the analysis on Sunday, Nov. 12, at the annual scientific sessions of the American Heart Association, in Chicago.

The study was supported by a young investigator award from the Association of Black Cardiologists and the Duke Clinical Research Institute.

"Past studies from which risk factors have been derived provide great information about heart disease in white men, but the studies have included few minorities and women," Thomas said. "Cardiovascular disease is the leading cause of death for blacks and whites in the United States, and yet there is a paucity of information on the long-term prognosis for blacks."

For the analysis, Thomas and colleagues consulted the Duke Database for Cardiovascular Disease, a compilation of data on heart patients who come to Duke University Medical Cent
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
12-Nov-2006


Page: 1 2 3

Related medicine news :

1. Health-care inequities underscore racial disparities in prostate cancer
2. Risk of birth complications varies between racial groups
3. Health-care delivery contributes to racial disparity in colorectal cancer
4. $36.4 billion a year: Cost of HIV/AIDS highlights racial and ethnic disparities
5. Study examines link between racial discrimination and mental and physical health
6. Our racial identity affects who we see
7. Multiracial youth more likely to engage in violent behavior, substance abuse
8. Study shows racial/ethnic disparities in medical/oral health status and care for minority children
9. Mammography screenings for breast cancer show racial and ethnic disparities
10. Age, sex, racial disparities in heart attack hospital transfer patterns
11. Hypertension data may mask racial disparities among Hispanics

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Wide racial disparities found coronary artery disease deaths

(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: